DDR1 and colonic neoplasm: In summary, anti‐DDR1 ADC was highly efficacious in DDR1‐expressing colon cancer xenograft models and exhibited acceptable safety profiles in preliminary animal studies, suggesting that anti‐DDR1 ADC may be a promising therapeutic for the treatment of patients with colon cancer.